bay-k-8644 has been researched along with fluoxetine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kecskeméti, V; Koller, A; Pacher, P; Ungvari, Z | 1 |
| Koller, A; Pacher, P; Ungvari, Z | 1 |
| Egami, K; Jinnah, HA; Kasim, S | 1 |
3 other study(ies) available for bay-k-8644 and fluoxetine
| Article | Year |
|---|---|
Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Cerebral Arteries; Dose-Response Relationship, Drug; Endothelium, Vascular; Fluoxetine; In Vitro Techniques; Male; Norepinephrine; Potassium Channels; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 1999 |
Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [Ca2+]i.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arterioles; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Dose-Response Relationship, Drug; Fluoxetine; In Vitro Techniques; Male; Muscle Tonus; Muscle, Skeletal; Muscle, Smooth, Vascular; Nifedipine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2000 |
Self-biting induced by activation of L-type calcium channels in mice: serotonergic influences.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 5,7-Dihydroxytryptamine; Animals; Brain; Calcium Channel Agonists; Calcium Channels, L-Type; Clorgyline; Female; Fenclonine; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Self Mutilation; Serotonin; Serotonin Antagonists | 2002 |